Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Can-Fite Biopharma Ltd (CANF) had Weighted-Average Shares Outstanding (Diluted) of 0.82M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.41M |
|
$-9.83M |
|
-- |
|
$0.41M |
|
$10.36M |
|
$-9.95M |
|
$0.12M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-9.95M |
|
$-9.93M |
|
0.82M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
0.82M |
$-11.94 |
|
$-11.94 |
|
| Balance Sheet Financials | |
$9.44M |
|
$0.01M |
|
$0.07M |
|
$9.51M |
|
$2.73M |
|
-- |
|
$1.19M |
|
$3.92M |
|
$5.59M |
|
$5.59M |
|
$5.59M |
|
1.31M |
|
| Cash Flow Statement Financials | |
$-8.95M |
|
$-0.00M |
|
$9.64M |
|
$4.83M |
|
$5.53M |
|
$0.70M |
|
$0.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.46 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2456.79% |
|
-2456.79% |
|
-2450.86% |
|
-2426.67% |
|
-2426.67% |
|
$-8.95M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
-- |
|
-- |
|
-175.75% |
|
-175.75% |
|
-103.30% |
|
-175.75% |
|
$4.27 |
|
$-10.88 |
|
$-10.87 |
|